Kid-size doses of Pfizer's COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
U.S. Surgeon General Vivek Murthy on Friday said Americans who got a Pfizer-BioNTech or Moderna vaccine for COVID-19 should feel comfortable in getting the same brand as a booster after federal officials made it easier for Americans to shop around.
Kid-size doses of Pfizer's COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
U.S. Surgeon General Vivek Murthy on Friday said Americans who got a Pfizer-BioNTech or Moderna vaccine for COVID-19 should feel comfortable in getting the same brand as a booster after federal officials made it easier for Americans to shop around.
The U.S. on Thursday donated its 200 millionth COVID-19 shot to help vaccinate the rest of the world, the White House announced. The Biden administration aims to lead a global vaccination campaign even as it rolls out boosters for domestic use, which critics say diverts doses from those who are in greater need around the world.